1[1]Holman RR et al.UKPDS Study.Diabetes Care 1999;22:966-964.
2[3]Home PD,Capaldo B,Burrin TM,et al.A crossover com parison of continuous subcutaneous insulin infusion(CSII)against multiple insulin injections in insulin-dependent diabetic subject improved control with CSIl.Diabetes Care 1982;5:466.
3[4]Paolisso G,Scheen AJ,Giugliano D,et al.Palsatile insulin delivery has great metabolic effects than contiuous hormone administration in man:importance of pulse frequency.J Clin Endocrinol Metab 1991;72:607.
4[5]Del Prato S,Tiengo A.The importance of first-phase insulin secretion:implications for the therapy of type 2 diabetes mellitus.Diabetes Metab Res Rev 2001;17(3):164-174.
5Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
6Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
7Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
8Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
9Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
10Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
4Pańkowska E,B?azik M,Dziechciarz P,et al.Continuous subcutaneous insulin infusion vs.multiple daily injections in children with type 1 diabetes:a systematic review and meta-analysis of randomized control trials.Pediatr Diabetes,2008 Aug 27[Epub ahead of print].
5Pickup JC,Sutton AJ.Severe hypoglycaemia and glycaemic control in Type 1 diabetes:meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.Diabet Med,25(7):765-74,2008.
6Weng J,Li Y,Xu W,et al.Effect of intensive insulin therapy on betacell function and glycaemic control in patients with newly diagnosed type 2 diabetes:a multicentre randomised parallel-group trial.Lancet,2008,371(9626):1753-1760.
7Jeitler K,Horvath K,Berghold A,et al.Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus:systematic review and meta-analysis.Diabetologia,2008,51(6):941-951.
8UK Prospective Diabetes Study:Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).Lancet,1998,352:837-853.
9UK rospective Diabetes Study:Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).Lancet,1998,352:854-865.
10Chen HS,Wu TE,Jap TS,et al.Beneficial effects of insulin on glycemic control andβ-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.Diabetes Care,2008,31:1927-1932.
